trial

Open Label Extension Study of NCT06221852

NCTId NCT06558201
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Enrolling By Invitation
Enrollment 50 (estimated)
Sponsored by Mclean Hospital
Primary completion 2027-09-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Enrolling By Invitation
Enrollment
50 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2024-08-28
Primary completion
2027-09-30
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Ketogenic Diet

Sponsors

Mclean HospitalLead Sponsor
Baszucki Family FoundationCollaborator

Investigators

1
Virginie-Anne Chouinard, MDPrincipal Investigator

Sites

1 total
Belmont, United States

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2027-09-30
Status
ENROLLING_BY_INVITATION
relationships
The graph out of here
drug
Ketogenic Diet
drug
lead_sponsor
Mclean Hospital
company
collaborator
Baszucki Family Foundation
company
indication
Bipolar Disorder
indication
Insulin Resistance
indication
Schizoaffective Disorder
indication
investigator
Virginie-Anne Chouinard, MD
person